Philipps-Universitat Marburg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Philipps-Universitat Marburg.The latest application filed is for "dual inhibition of plexin-b1 and plexin-b2".

Company Profile

1.9.16

Philipps-Universitat Marburg - Marburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dual Inhibition Of Plexin-b1 And Plexin-b2 App 20220162616 - WORZFELD; Thomas ; et al.	2022-05-26
Preparation Of Metal Fluorides And Separation Processes App 20220153607 - CHEMNITZ; Tobias ; et al.	2022-05-19
Neutralizing Antibodies Against Sars-related Coronavirus App 20210371503 - Becker; Stephan ; et al.	2021-12-02
Device And Method For Determining The Impedance On A Tooth App 20210169363 - Gente; Michael ; et al.	2021-06-10
Molecular White-light Emitter App 20200328358 - Beyer; Andreas ; et al.	2020-10-15
Use of at least one binary group 15 element compound, a 13/15 semiconductor layer and binary group 15 element compounds Grant 10,269,562 - Von Haenisch , et al.	2019-04-23
Use Of At Least One Binary Group 15 Element Compound, A 13/15 Semiconductor Layer And Binary Group 15 Element Compounds App 20170243740 - VON HAENISCH; Carsten ; et al.	2017-08-24
Compounds As Ppar Beta/delta Inhibitors For Treating Ppar Beta/delta-mediated Diseases App 20150018411 - Diederich; Wibke ; et al.	2015-01-15
Hydrophobic flourinated coating Grant 8,871,881 - Greiner , et al. October 28, 2	2014-10-28
N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic Grant 8,865,865 - Steinmetzer , et al. October 21, 2	2014-10-21
Cyclic Tripeptide Mimetics As Plasmin Inhibitors App 20140213781 - Steinmetzer; Torsten ; et al.	2014-07-31
Peptide Derivatives Of Exendin-4 App 20130095037 - GOTTHARDT; Martin ; et al.	2013-04-18
Peptide derivatives of exendin-4 Grant 8,268,781 - Gotthardt , et al. September 18, 2	2012-09-18
Intraocular lens device for the improvement of vision in case of retinal diseases Grant 8,206,442 - Sel , et al. June 26, 2	2012-06-26
Electrospun Polymer Fibers Comprising Particles of Bacteria-Containing Hydrogels App 20120107900 - Greiner; Andreas ; et al.	2012-05-03
Non-Viral Transfection Agent App 20120083037 - Wendorff; Joachim H. ; et al.	2012-04-05
N-terminally Modified Tetrapeptide Derivatives Having A C-terminal Arginine Mimetic App 20110312873 - Steinmetzer; Torsten ; et al.	2011-12-22
Invention concerning agricultural active substances Grant 8,017,061 - Greiner , et al. September 13, 2	2011-09-13
Production of metal nano- and mesofibers Grant 7,981,354 - Wendorff , et al. July 19, 2	2011-07-19
Hydrolytically Decomposable Ionic Copolymers App 20110160426 - Greiner; Andreas ; et al.	2011-06-30
cDNA production from cells after laser microdissection Grant 7,915,016 - Liss March 29, 2	2011-03-29
Cdna Production from Cells After Laser Microdissection App 20080261275 - Liss; Birgit	2008-10-23
Device for the intraperitoneal application of a fluid which features ozone or ozonized oxygen into a human or animal body and use therefor App 20070039626 - Schulz; Siegfried	2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.